{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T12:18:58Z","timestamp":1781871538337,"version":"3.54.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.ejphar.2011.04.051","type":"journal-article","created":{"date-parts":[[2011,5,3]],"date-time":"2011-05-03T01:21:37Z","timestamp":1304385697000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome"],"prefix":"10.1016","volume":"662","author":[{"given":"Yoshiyuki","family":"Sasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiichi","family":"Iizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroko","family":"Makihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryutaro","family":"Teraoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Tsuneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoji","family":"Hokao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Aburada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.04.051_bb0005","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1210\/endo.139.11.6324","article-title":"Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin","volume":"139","author":"Bergen","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0010","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/modpathol.3800450","article-title":"Expression profiling of endogenous secretory receptor for advanced glycation end products in human organs","volume":"18","author":"Cheng","year":"2005","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.hepres.2005.09.022","article-title":"Lessons from animal models of NASH","volume":"33","author":"Diehl","year":"2005","journal-title":"Hepatol. Res."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0020","first-page":"233","article-title":"Commonly used animal models of non-alcoholic steatohepatitis","volume":"8","author":"Fan","year":"2009","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0025","doi-asserted-by":"crossref","first-page":"17118","DOI":"10.1074\/jbc.M407539200","article-title":"A dominant negative peroxisome proliferator-activated receptor-\u03b3 knock-in mouse exhibits features of the metabolic syndrome","volume":"280","author":"Freedman","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0030","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2147\/VHRM.S1434","article-title":"Update on the use of fibrates: focus on Bezafibrate","volume":"4","author":"Goldenberg","year":"2008","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0035","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/hep.1840040328","article-title":"Quantitative microscopy comparison of peroxisome proliferation by the lipid-regulating agent gemfibrozil in several species","volume":"4","author":"Gray","year":"1984","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0040","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute scientific statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0045","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/01.ATV.0000256469.06782.d5","article-title":"Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level","volume":"27","author":"Hiuge","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0050","doi-asserted-by":"crossref","first-page":"E1014","DOI":"10.1152\/ajpendo.00105.2005","article-title":"Indispensable role of mitochondrial UCP1 for antiobesity effect of beta3-adrenergic stimulation","volume":"290","author":"Inokuma","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0055","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/S0891-5849(02)00906-1","article-title":"Multidrug resistance-associated protein2 (MRP2) plays an important role in the biliary excretion of glutathione conjugates of 4-hydroxynonenal","volume":"33","author":"Ji","year":"2002","journal-title":"Free Radic Biol. Med."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0060","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1021\/tx034067m","article-title":"Multidrug resistance-associated protein 2 (MRP2) enhances 4-hydroxynonenal-induced toxicity in Madin\u2013Darby canine kidney II cells","volume":"17","author":"Ji","year":"2004","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0065","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1053\/j.gastro.2003.08.029","article-title":"Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin","volume":"125","author":"Kamada","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.2337\/diacare.27.6.1375","article-title":"Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults","volume":"27","author":"Kanaya","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0075","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3949\/ccjm.75.10.721","article-title":"Nonalcoholic fatty liver disease: a manifestation of the metabolic syndrome","volume":"75","author":"Kim","year":"2008","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0080","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0085","first-page":"57","article-title":"Oxidative stress and enzymatic antioxidant status in patients with nonalcoholic steatohepatitis","volume":"34","author":"Koruk","year":"2004","journal-title":"Ann. Clin. Lab. Sci."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0090","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/jhep.2003.50048","article-title":"Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease","volume":"37","author":"Li","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0095","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0100","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.exer.2006.10.020","article-title":"4-Hydroxynonenal, a product of oxidative stress, leads to an antioxidant response in optic nerve head astrocytes","volume":"84","author":"Malone","year":"2007","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0105","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0110","series-title":"Joslin's Diabetes Mellitus","first-page":"291","article-title":"Rodent Models for the Study of Diabetes","author":"Mathews","year":"2005"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0115","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.febslet.2006.04.028","article-title":"The metabolic syndrome and adipocytokines","volume":"580","author":"Matsuzawa","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0120","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.ejphar.2006.02.028","article-title":"Effects of bezafibrate, PPAR pan-agonist, and GW501516, PPAR\u03b4 agonist, on development of steatohepatitis in mice fed a methionine- and choline-deficient diet","volume":"536","author":"Nagasawa","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0125","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1538\/expanim.55.109","article-title":"Type 2 diabetes mellitus in obese mouse model induced by monosodium glutamate","volume":"55","author":"Nagata","year":"2006","journal-title":"Exp. Anim."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0130","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1124\/mol.108.052928","article-title":"Bezafibrate at clinically relevant doses decreases serum\/liver triglycerides via down-regulation of sterol regulatory element-binding protein-1c in mice: a novel peroxisome proliferator-activated receptor \u03b1-independent mechanism","volume":"75","author":"Nakajima","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0135","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2007.11.016","article-title":"Monosodium glutamate (MSG): a villain and promoter of liver inflammation and dysplasia","volume":"30","author":"Nakanishi","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0140","doi-asserted-by":"crossref","first-page":"E1213","DOI":"10.1152\/ajpendo.00340.2006","article-title":"Bezafibrate regulates the expression and enzyme activity of 11\u03b2-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes","volume":"292","author":"Nakano","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0145","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5551\/jat.12.211","article-title":"A nuclear receptor-mediated choleretic action of fibrates is associated with enhanced canalicular membrane fluidity and transporter activity mediating bile acid-independent bile secretion","volume":"12","author":"Nishioka","year":"2005","journal-title":"J. Atheroscler. Thromb."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0150","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1053\/j.gastro.2007.03.055","article-title":"Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease","volume":"132","author":"Parekh","year":"2007","journal-title":"Gasteroenterology"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0155","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/sj.bjp.0706041","article-title":"The dual PPARalpha\/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats","volume":"144","author":"Pickavance","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0160","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0003-9861(03)00002-X","article-title":"Characterization of multidrug resistance-associated protein 2 in the hepatocellular disposition of 4-hydroxynonenal","volume":"411","author":"Reichard","year":"2003","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0165","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.lfs.2009.07.017","article-title":"Dose dependent development of diabetes mellitus and non-alcoholic steatohepatitis in monosodium glutamate-induced obese mice","volume":"85","author":"Sasaki","year":"2009","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0170","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.3748\/wjg.14.2474","article-title":"Nonalcoholic fatty liver disease: an overview of current insights in pathogenesis, diagnosis and treatment","volume":"14","author":"Schreuder","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0175","first-page":"437","article-title":"A novel technique for the determination of body fat by computed tomography","volume":"7","author":"Tokunaga","year":"1983","journal-title":"Int. J. Obes."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1254\/jjp.77.247","article-title":"The effect of acute cold exposure and norepinephrine on uncoupling protein gene expression in brown adipose tissue of monosodium glutamate-obese mice","volume":"77","author":"Tsukahara","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.04.051_bb0185","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1080\/00498250500136676","article-title":"Effects of fibrates on human organic anion-transporting polypeptide 1B1-, multidrug resistance protein 2- and P-glycoprotein-mediated transport","volume":"35","author":"Yamazaki","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejphar.2011.04.051_bb0190","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1177\/153537020422900303","article-title":"Hypothalamic melanocortin system regulates sympathetic nerve activity in brown adipose tissue","volume":"229","author":"Yasuda","year":"2004","journal-title":"Exp. Biol. Med."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911004705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911004705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:13:31Z","timestamp":1757974411000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911004705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":38,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0014299911004705"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.04.051","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of bezafibrate in nonalcoholic steatohepatitis model mice with monosodium glutamate-induced metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.04.051","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}